+

WO2007052157A3 - Composition de depigmentation destinee a la peau et comprenant de l'adapalene, au moins un agent de depigmentation et au moins un agent anti-inflammatoire - Google Patents

Composition de depigmentation destinee a la peau et comprenant de l'adapalene, au moins un agent de depigmentation et au moins un agent anti-inflammatoire Download PDF

Info

Publication number
WO2007052157A3
WO2007052157A3 PCT/IB2006/003725 IB2006003725W WO2007052157A3 WO 2007052157 A3 WO2007052157 A3 WO 2007052157A3 IB 2006003725 W IB2006003725 W IB 2006003725W WO 2007052157 A3 WO2007052157 A3 WO 2007052157A3
Authority
WO
WIPO (PCT)
Prior art keywords
depigmenting
agent
adapalene
skin
composition
Prior art date
Application number
PCT/IB2006/003725
Other languages
English (en)
Other versions
WO2007052157A2 (fr
Inventor
Isabelle Pelisson
Andre Jomard
Original Assignee
Galderma Res & Dev
Isabelle Pelisson
Andre Jomard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0509003A external-priority patent/FR2890314B1/fr
Application filed by Galderma Res & Dev, Isabelle Pelisson, Andre Jomard filed Critical Galderma Res & Dev
Priority to CA002616915A priority Critical patent/CA2616915A1/fr
Priority to EP06842260A priority patent/EP1926484A2/fr
Publication of WO2007052157A2 publication Critical patent/WO2007052157A2/fr
Publication of WO2007052157A3 publication Critical patent/WO2007052157A3/fr
Priority to US12/041,367 priority patent/US20080219936A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition de dépigmentation destinée à la peau et comprenant, dans un milieu acceptable sur le plan physiologique, de l'adapalène, au moins un agent de dépigmentation et au moins un agent anti-inflammatoire et l'utilisation cosmétique ou pharmaceutique de celle-ci.
PCT/IB2006/003725 2005-09-02 2006-08-31 Composition de depigmentation destinee a la peau et comprenant de l'adapalene, au moins un agent de depigmentation et au moins un agent anti-inflammatoire WO2007052157A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002616915A CA2616915A1 (fr) 2005-09-02 2006-08-31 Composition de depigmentation destinee a la peau et comprenant de l'adapalene, au moins un agent de depigmentation et au moins un agent anti-inflammatoire
EP06842260A EP1926484A2 (fr) 2005-09-02 2006-08-31 Composition de depigmentation destinee a la peau et comprenant de l'adapalene, au moins un agent de depigmentation et au moins un agent anti-inflammatoire
US12/041,367 US20080219936A1 (en) 2005-09-02 2008-03-03 Skin depigmenting compositions comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0509003A FR2890314B1 (fr) 2005-09-02 2005-09-02 Compositiondepigmentante de la peau comprenant de l'adapalene au moins un agent depigmentant et au moins un agent anti-inflammatoire
FR0509003 2005-09-02
US71776705P 2005-09-19 2005-09-19
US60/717,767 2005-09-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/041,367 Continuation US20080219936A1 (en) 2005-09-02 2008-03-03 Skin depigmenting compositions comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent

Publications (2)

Publication Number Publication Date
WO2007052157A2 WO2007052157A2 (fr) 2007-05-10
WO2007052157A3 true WO2007052157A3 (fr) 2007-10-04

Family

ID=38006259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/003725 WO2007052157A2 (fr) 2005-09-02 2006-08-31 Composition de depigmentation destinee a la peau et comprenant de l'adapalene, au moins un agent de depigmentation et au moins un agent anti-inflammatoire

Country Status (3)

Country Link
EP (1) EP1926484A2 (fr)
CA (1) CA2616915A1 (fr)
WO (1) WO2007052157A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
WO2001082880A2 (fr) * 2000-05-03 2001-11-08 Goodman David S Preparation topique pour le traitement de la perte des cheveux
FR2833841A1 (fr) * 2001-12-21 2003-06-27 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
WO2004021967A2 (fr) * 2002-09-05 2004-03-18 Galderma Research & Development, S.N.C. Composition de depigmentation pour la peau comprenant de l'adapalene et au moins un agent de depigmentation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
WO2001082880A2 (fr) * 2000-05-03 2001-11-08 Goodman David S Preparation topique pour le traitement de la perte des cheveux
FR2833841A1 (fr) * 2001-12-21 2003-06-27 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
WO2004021967A2 (fr) * 2002-09-05 2004-03-18 Galderma Research & Development, S.N.C. Composition de depigmentation pour la peau comprenant de l'adapalene et au moins un agent de depigmentation

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"Long-term benefits of adapalene cream maintenance therapy for the treatment of mild to moderate acne and postinflammatory hyperpigmentation", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, C.V. MOSBY, ST. LOUIS, MO, US, vol. 52, no. 3, March 2005 (2005-03-01), pages P19, XP004840275, ISSN: 0190-9622 *
BUSHKELL L L: "Letter: Bleaching by benzoyl peroxide.", ARCHIVES OF DERMATOLOGY SEP 1974, vol. 110, no. 3, September 1974 (1974-09-01), pages 465, XP009086259, ISSN: 0003-987X *
GOLLNICK H ET AL: "TOPICAL THERAPY IN ACNE", JEADV. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 11, no. SUPPL 1, September 1998 (1998-09-01), pages S08 - S12, XP000901307, ISSN: 0926-9959 *
KANG SEWON ET AL: "Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial.", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. JUL 2003, vol. 49, no. 1, July 2003 (2003-07-01), pages 83 - 90, XP002382627, ISSN: 0190-9622 *
KATSAMBAS A D ET AL: "Depigmenting and Bleaching Agents: Coping with Hyperpigmentation", CLINICS IN DERMATOLOGY, J.B. LIPPINCOTT, PHILADELPHIA, PA, US, vol. 19, 2001, pages 483 - 488, XP002310205, ISSN: 0738-081X *
LAYTON ET AL: "Acne vulgaris and similar eruptions", ACNE AND ROSACEA, vol. 33, no. 1, 1 January 2005 (2005-01-01), pages 44 - 48, XP005769980 *
MILLIKAN L E: "ADAPALENE: AN UPDATE ON NEWER COMPARATIVE STUDIES BETWEEN THE VARIOUS RETINOIDS", INTERNATIONAL JOURNAL OF DERMATOLOGY, INT. SOCIETY OF TROPICAL DERMATOLOGY INC.,, US, vol. 39, no. 10, 2000, pages 784 - 788, XP001100048, ISSN: 0011-9059 *

Also Published As

Publication number Publication date
WO2007052157A2 (fr) 2007-05-10
EP1926484A2 (fr) 2008-06-04
CA2616915A1 (fr) 2007-05-10

Similar Documents

Publication Publication Date Title
WO2008087354A3 (fr) Gel creme comprenant au moins un retinoide et du péroxyde de benzoyle
EP2224973A4 (fr) Conservateurs pour compositions cosmétiques, de toilette et pharmaceutiques
WO2004021967A3 (fr) Composition de depigmentation pour la peau comprenant de l'adapalene et au moins un agent de depigmentation
IL203915A (en) Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol
WO2004021968A3 (fr) Solution destinee a une application ungueale et peri-ungueale
WO2007064885A3 (fr) Compositions, procedes, dispositifs et systemes pour soins buccaux
BR0115810B1 (pt) composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos.
IL174479A (en) The derivatives of myastrin, pharmaceutical preparations containing them and their uses
ZA200706254B (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
WO2009077693A3 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene
WO2007031883A3 (fr) Composition contenant au moins un derive d'acide naphtoique et au moins un compose de type polymere de polyurethane ou des derives de ce compose, procedes de fabrication et utilisations de cette composition
EP1708719A4 (fr) Compositions pharmaceutiques aqueuses de 2,6-diisopropylphenol (propofol) et leurs utilisations
MXPA05013667A (es) Composiciones de dos componentes para el cuidado de la piel que comprenden un agente autobronceante.
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof
IL195935A0 (en) 18-methyl-19-nor-androst-4-en 17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
WO2008145747A3 (fr) Nouvel hydratant et son utilisation
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
MX2007007427A (es) Composicion que comprende adapaleno solubilizado con ciclodextrinas.
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
WO2004041173A3 (fr) Compositions permettant de foncer la peau et/ou les cheveux
WO2008050157A3 (fr) Formulations d'huile ozonisée
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
GB0501942D0 (en) Cosmetic, veterinary, pharmaceutical and therapeutic compositions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006842260

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2616915

Country of ref document: CA

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06842260

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006842260

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载